Showing results (1-10 of 240) with videos related to
Sort By:
Pageof 24
JPMA. the Journal of the Pakistan Medical Association|July 24, 2004
Increased expression of HLA DR2 in acquired aplastic anemia and its impact on response to immunosuppressive therapyM Usman, S N Adil, T Moatter, et al.The Journal of the Association of Physicians of India|June 19, 2007
Chronic phase chronic myeloid leukemia: response of imatinib mesylate and significance of Sokal score, age and disease duration in predicting the hematological and cytogenetic responseM Usman, N N Syed, G N Kakepoto, et al.JPMA. the Journal of the Pakistan Medical Association|July 24, 2004
Polycythemia vera and idiopathic erythrocytosis: comparison of clinical and laboratory parametersM Usman, F Bilwani, G N Kakepoto, et al.JPMA. the Journal of the Pakistan Medical Association|April 3, 2004
Hematologic and cytogenetic findings in eleven chronic myelogenous leukemia patients treated with imatinib mesylate at a tertiary care hospitalM Usman, G N Kakepoto, S N Adil, et al.JPMA. the Journal of the Pakistan Medical Association|November 19, 2003
Outcome of adult acute lymphoblastic leukemia: a single center experienceM Usman, I Burney, A Nasim, et al.Transplant Infectious Disease : an Official Journal of the Transplantation Society|January 4, 2014
Bloodstream and central line isolates from hematopoietic stem cell transplant recipients: data from a developing countryN Ali, S N Adil, M U ShaikhJPMA. the Journal of the Pakistan Medical Association|October 6, 2004
Frequency of hereditary thrombophilia: an AKUH experienceS Khalid, R Sajid, S N Adil, et al.Journal of Environmental Management|January 9, 2018
Comment on "thermal remediation alters soil properties - A review"M UsmanSingapore Medical Journal|June 3, 2011
Outcome of adult patients with acute lymphoblastic leukaemia receiving the MRC UKALL XII protocol: a tertiary care centre experienceM U Shaikh, N Ali, S N Adil, et al.JPMA. the Journal of the Pakistan Medical Association|January 24, 2004
Use of intravenous anti-D in patients with refractory and relapsed immune thrombocytopenic purpuraR Sajid, S N Adil, Z Fadoo, et al.Pageof 24